Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
4DMT to Participate in the 2024 Cantor Global Healthcare Conference
-
Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
-
Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
-
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
-
Skillvue secures $2.8M funding round for AI-based skills assessment platform for candidates and employees
-
Alliance Trust PLC - Net Asset Value
-
DSV, 1130 - SHARE BUYBACK IN DSV A/S
-
UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
-
Affimed Appoints Shawn M. Leland as Chief Executive Officer
-
Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization Method
-
Tourmaline Bio to Present at Upcoming Investor Conferences
-
Bishop Street Underwriters, Announces Joint Venture with Skyward Specialty Insurance
-
CoinW Unveils New Futures Features: Futures Grid and Futures CTA for Smarter Trading
-
NCL Corporation Ltd. Announces Proposed Offering of Senior Notes
-
H World Group Limited Announces Change of Chief Financial Officer
-
Invesco Ltd: Form 8.3 - REA Group Ltd; Opening Position Disclosure
-
CoinW Unveils Nexus Program at Coinfest Asia to Expand Global Reach
-
Forensic Accounting and Litigation Expert Juli Saitz Joins FTI Consulting as Senior Managing Director
-
Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
-
First Helium Reminds Participants of Webinar to Present High Impact Exploration Targets for Fall of 2024
-
Spectral Medical Provides August Tigris Trial Update
-
PharmaCorp Completes Acquisition of a Pharmacy in Western Canada
-
Revival Gold Restructures and Extends Beartrack Earn-In Terms
-
ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.
-
Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference
-
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 60th Annual Meeting of the European Association for the Study of Diabetes
-
Praxis Precision Medicines announces positive topline results from the EMBOLD study in SCN2A and 8A developmental epilepsies, highlighting the disease-modifying potential of relutrigine
-
Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences
-
InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases
-
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
-
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
-
Skyharbour Commences Summer Diamond Drilling Program at its Moore Uranium Project, Saskatchewan
-
MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
-
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
-
BlueRock Therapeutics announces FDA clearance of IND application for investigational iPSC-derived cell therapy OpCT-001 for the treatment of primary photoreceptor diseases
-
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
-
Arbutus to Participate in Two Upcoming Investor Conferences
-
LED Lighting and EV Charging Solutions Provider Orion Energy Systems to Attend H.C. Wainwright Investment Conference Sept. 9th and 10th in New York City
-
Invesco Ltd: Form 8.3 -Rightmove PLC; Opening Position Disclosure
-
Freight Technologies Announces Extinguishment of $1.1M of Outstanding Debt and Convertible Notes
-
TopBuild to Participate in Fireside Chat at Jefferies Industrials Conference
-
JCS Solutions Engages Federal Digital Transformation Executive Carter Raines as First Chief Growth Officer
-
ADC Therapeutics to Present at Upcoming Investor Conferences
-
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
-
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
-
Goliath Intercepts The Highest Concentration Of Visible Gold To Date At Surebet Where 66% Of 2024 Drill Holes Contain Visible Gold, Discovers New Deep Mineralized Zone 1.2 Km Below Surface, Remains O
-
Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
-
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
-
Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Di
